Top Sell
| Security ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Acadia Pharmaceuticals | 23 | 1 | 3 | 1 | €15.62 | €32.59 | 108.678% |
| Agenus Inc. | 2 | 2 | 0 | 0 | €0.41 | €7.30 | 1664.911% |
| Anavex Life Sciences Corp | 0 | 2 | 0 | 0 | €3.67 | - | - |
| Aspira Womens Health Inc. | 0 | 1 | 0 | 0 | €2.92 | - | - |
| Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | €0.64 | €3.00 | 371.550% |
| Bellicum Pharmaceuticals Inc. | 0 | 13 | 0 | 0 | €0.064 | - | - |
| BioLine RX Ltd ADR | 0 | 2 | 0 | 0 | €0.60 | - | - |
| Bluebird Bio Inc. | 4 | 6 | 0 | 0 | €0.88 | €8.82 | 906.585% |
| Bristol-Myers Squibb | 11 | 3 | 1 | 0 | €41.00 | €67.64 | 64.973% |
| Carbylan Therapeutics Inc | 1 | 1 | 0 | 0 | €9.80 | €22.00 | 124.490% |
| Chimerix Inc. | 4 | 1 | 0 | 0 | €0.92 | €5.51 | 497.465% |
| Coherus Bioscien. | 2 | 2 | 0 | 0 | €2.11 | €3.00 | 42.315% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 2 | 0 | €35.60 | €50.00 | 40.449% |
| Corvus Pharmaceuticals Inc | 4 | 1 | 0 | 1 | €1.44 | €5.10 | 253.377% |
| Cytomx Therapeutics Inc | 2 | 2 | 2 | 2 | €4.55 | €50.00 | 999.384% |
| Eagle Pharmaceuticals Inc | 0 | 1 | 0 | 0 | €3.84 | - | - |
| Evoke Pharma Inc. | 0 | 22 | 0 | 0 | €0.41 | - | - |
| Evotec SE | 4 | 1 | 0 | 0 | €9.84 | €21.50 | 118.496% |
| Fibrogen Inc. | 1 | 4 | 0 | 1 | €1.03 | €0.000 | -100.000% |
| Grifols S.A. ADR | 0 | 1 | 0 | 0 | €5.90 | - | - |
| Immuron | 0 | 1 | 0 | 1 | €2.16 | - | - |
| Ionis Pharmaceuticals Inc. | 17 | 5 | 4 | 0 | €40.57 | €56.86 | 40.158% |
| Ironwood Pharmaceuticals | 7 | 1 | 0 | 0 | €7.70 | €19.32 | 150.964% |
| Karyopharm Therapeutics Inc. | 7 | 2 | 0 | 0 | €1.03 | €3.65 | 255.694% |
| Larimar Therapeutics Inc. | 2 | 4 | 0 | 0 | €6.15 | €7.00 | 13.821% |